TargetComplement factor B(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 3.40E+3nMAssay Description:Inhibition of C3 convertaseMore data for this Ligand-Target Pair
TargetComplement factor B(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 1.20E+4nMAssay Description:Inhibition of human C3/C5 convertase assessed as inhibition of C3 cleavageMore data for this Ligand-Target Pair